Supplemental Figure 3 from GD2-Targeting CAR T-cell Therapy for Patients with GD2⁺ Medulloblastoma

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplemental Figure 3 from GD2-Targeting CAR T-cell Therapy for Patients with GD2<sup>+</sup> Medulloblastoma2024
2. 2Supplemental Figure 6 from GD2-Targeting CAR T-cell Therapy for Patients with GD2<sup>+</sup> Medulloblastoma2024
3. 3Supplemental Figure 6 from GD2-Targeting CAR T-cell Therapy for Patients with GD2<sup>+</sup> Medulloblastoma2024
4. 4Supplemental Figure 1 from GD2-Targeting CAR T-cell Therapy for Patients with GD2<sup>+</sup> Medulloblastoma2024
5. 5Supplemental Figure 4 from GD2-Targeting CAR T-cell Therapy for Patients with GD2<sup>+</sup> Medulloblastoma2024